Summary of Study ST000367
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000292. The data can be accessed directly via it's Project DOI: 10.21228/M89C74 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000367 |
Study Title | Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator b-glucan in a two-case ex vivo non-small cell lung cancer study |
Study Type | tracer |
Study Summary | [U-13C]-Glu SIRM study of ex vivo tissue slices in matched-pair tumor/non-tumor ex vivo tissue slices from two human patients with and without beta-glucan. |
Institute | University of Kentucky |
Department | CESB |
Last Name | Fan |
First Name | Teresa |
Address | Rm 516 Biopharm Complex, 789 S. Limestone St.,Univ. of Kentucky, Lexington, KY 40536 |
twmfan@gmail.com | |
Phone | - |
Submit Date | 2016-03-10 |
Analysis Type Detail | LC-MS |
Release Date | 2016-03-21 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000292 |
Project DOI: | doi: 10.21228/M89C74 |
Project Title: | Systems Biochemistry in Lung Cancer: toward a mechanistic understanding of NSCLC |
Project Summary: | The program comprises three project areas utilizing stable isotope resolved metabolomics to gain a mechanistic understanding of NSCLC in situ. The projects combine cell culture, animal models and human subjects to define the influence of the tumor microenvironment on cancer progression. |
Institute: | University of Kentucky |
Last Name: | Lane |
First Name: | Andrew |
Address: | Rm 516 Biopharm Complex, 789 S. Limestone St.,Univ. of Kentucky, Lexington, KY 40536 |
Email: | andrewnlane@gmail.com |
Phone: | - |
Subject:
Subject ID: | SU000388 |
Subject Type: | Animal |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Subject Comments: | tissue_slice |
Species Group: | Mammals |
Factors:
Subject type: Animal; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment | Tissue type |
---|---|---|---|
SA016507 | 34_UK49 | 13C6Glc_100ug/ml b-glucan | nontumor |
SA016508 | 33_UK49 | 13C6Glc_100ug/ml b-glucan | nontumor |
SA016509 | 15_UK21 | 13C6Glc_100ug/ml b-glucan | nontumor |
SA016510 | 07_UK21 | 13C6Glc_100ug/ml b-glucan | tumor |
SA016511 | 03_UK49 | 13C6Glc_100ug/ml b-glucan | tumor |
SA016512 | 04_UK49 | 13C6Glc_100ug/ml b-glucan | tumor |
SA016513 | 31_UK49 | 13C6Glc | nontumor |
SA016514 | 32_UK49 | 13C6Glc | nontumor |
SA016515 | 13_UK21 | 13C6Glc | nontumor |
SA016516 | 05_UK21 | 13C6Glc | tumor |
SA016517 | 01_UK49 | 13C6Glc | tumor |
SA016518 | 02_UK49 | 13C6Glc | tumor |
Showing results 1 to 12 of 12 |
Collection:
Collection ID: | CO000382 |
Collection Summary: | 2 methods were used: Precellys homogenization (Precellys_homogenization_SOP-2015-04-09.pdf, measurements: IC-FTMS1) and Retsch homogenization (protocol: Retsch_homogenization_SOP-2015-09-27.pdf, measurements: IC-FTMS2) |
Collection Protocol Filename: | Precellys_homogenization_SOP-2015-04-09.pdf Retsch_homogenization_SOP-2015-09-27.pdf |
Collection Protocol Comments: | Precellys_homogenization_SOP-2015-04-09.pdf (IC-FTMS1), Retsch_homogenization_SOP-2015-09-27.pdf (IC-FTMS2) |
Sample Type: | Lung |
Treatment:
Treatment ID: | TR000402 |
Treatment Summary: | none |
Treatment Protocol Filename: | SIRM_ex_vivo_tissue_slices_protocol__Bio-protocol_6_e1730__2016.pdf |
Treatment Protocol Comments: | ex vivo tissue slice experiment with isotopic labeling. |
Sample Preparation:
Sampleprep ID: | SP000395 |
Sampleprep Summary: | Preparation of polar samples for GCMS, NMR, and IC-FTMS; Protein extraction and quantification |
Sampleprep Protocol Filename: | Extract_Polar_Lipid_Prot_Fan.pdf Extract_Protein_Quant_Fan.pdf |
Combined analysis:
Analysis ID | AN000600 | AN000601 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Ion Chromatography | Ion Chromatography |
Chromatography system | Thermo Dionex ICS-5000+ | Thermo Dionex ICS-5000+ |
Column | Unspecified | Unspecified |
MS Type | ESI | ESI |
MS instrument type | FT-ICR-MS | FT-ICR-MS |
MS instrument name | Thermo Fusion Tribrid Orbitrap | Thermo Fusion Tribrid Orbitrap |
Ion Mode | NEGATIVE | NEGATIVE |
Units | normalized corrected peak area | normalized corrected peak area |
Chromatography:
Chromatography ID: | CH000427 |
Instrument Name: | Thermo Dionex ICS-5000+ |
Column Name: | Unspecified |
Chromatography Type: | Ion Chromatography |
MS:
MS ID: | MS000533 |
Analysis ID: | AN000600 |
Instrument Name: | Thermo Fusion Tribrid Orbitrap |
Instrument Type: | FT-ICR-MS |
MS Type: | ESI |
MS Comments: | IC-FTMS1: Data were adjusted as follows: 1)Get raw XIC peak areas from TF33 -> 2)correct for protein content by adjusting the signals according by wet weight -> 3) correct for NA abundance. Some compounds were assigned using a sperate standard run, others were assigned because they were the only or the highest peak in the extracted ion chromatogram. (XIC). |
Ion Mode: | NEGATIVE |
MS ID: | MS000534 |
Analysis ID: | AN000601 |
Instrument Name: | Thermo Fusion Tribrid Orbitrap |
Instrument Type: | FT-ICR-MS |
MS Type: | ESI |
MS Comments: | IC-FTMS2: Data were adjusted as follows: 1)Get raw XIC peak areas from TF33 -> 2)correct for protein content by reconstituting the volumes according to tissue wet weight -> 3) correct for NA abundance. Some compounds were assigned using a sperate standard run, others were assigned because they were the only or the highest peak in the extracted ion chromatogram. (XIC). |
Ion Mode: | NEGATIVE |